In China, its incidence has an increasing trend (2.6%/year) in recent 5 years.
← all excerpts
Targeted inhibition of SIRT6 via engineered exosomes impairs tumorigenesis and metastasis in prostate cancer.
1
—
—
In China, its incidence has an increasing trend (2.6%/year) in recent 5 years.